Form 4: Schrodinger Executive Sells Shares for Tax Obligation

Schrodinger's President of Therapeutics R&D sold 1,366 shares to cover tax liabilities from RSU vesting.

Summary

• Karen Akinsanya, President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships at Schrodinger, Inc. (SDGR), reported a sale of common stock.
• On March 5, 2026, 1,366 shares of common stock were sold at a weighted average price of $12.903 per share.
• The sale was executed pursuant to a Rule 10b5-1 plan adopted on March 8, 2023.
• The purpose of the sale was to satisfy withholding tax liability incurred upon the vesting of restricted stock units (RSUs).
• This transaction was not a discretionary trade by the reporting person.
• Following the transaction, Karen Akinsanya beneficially owns 69,956 shares, which includes 63,545 unvested RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine, non-discretionary transaction by an executive to cover tax obligations related to RSU vesting, which is common practice and does not typically signal a change in company fundamentals or executive sentiment.

Positives

• The sale was pre-planned under a Rule 10b5-1 plan, indicating compliance with insider trading regulations and transparency.
• The transaction was non-discretionary, specifically for tax withholding, which is a routine event for executives receiving equity compensation.

Negatives

• A reduction in the direct share ownership by a key executive, although for a specific tax purpose.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 8, 2023.
• The sale represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ('RSUs').
• The sale does not represent a discretionary trade by the reporting person.

Industry Context

StockSavvy.ai notes that sales by executives to cover tax obligations upon the vesting of restricted stock units (RSUs) are a common and routine occurrence across industries. These transactions, especially when executed under a pre-arranged Rule 10b5-1 plan, are generally not interpreted as discretionary sales reflecting a change in management's sentiment about the company's future prospects, unlike open market discretionary sales.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in company outlook.
• Employees: No direct impact mentioned.

Key Dates

Keywords

Schrodinger, SDGR, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, 10b5-1 Plan, Executive Compensation